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Abstract 
Objective: To compare recurrence of intranasal polyps treated with intranasal polypectomy versus steroid use. 
Study Settings and Duration: ENT department Nishtar hospital Multan from 24th December 2017 to 23 June 2018. 
Study design: randomized controlled trial Material and methods: All 50 cases were divided in two groups M and 
S. Group M were given oral prednisone (30-60 mg) for 15-20 days in tapering regimen while patients in S group, 
intranasal polypectomy done. Information was collected through pre-designed Performa. Mean and standard 
deviation was calculated for quantitative variables such as age. Frequencies and percentages were calculated for 
qualitative variables such as gender and outcome variable i.e. recurrence. Chi-square test was applied to compare 
recurrence in both groups and P ≤ 0.05 was considered as significant. Results: The mean age of patients in group 
A was 34.49 ± 6.51years and in group B was 34.15 ± 6.97years. Male were 64.44% and 35.56% were females 
with ratio of 1.81:1. The mean duration of disease in group A was 5.81 ± 4.33 days and in group B was 5.75 ± 
4.56 days. Recurrence rate in Group A (steroid group) was 57.78% while in Group B (intranasal polypectomy 
group) was 22.22% (p =0.001) Conclusion: Intranasal polypectomy is more effective in terms of non-recurrence 
of nasal polyps as compared to steroid use in the management of nasal polyps. 
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INTRODUCTION 
Abnormal lesions which are resulted from different types of diseases mechanisms within intra nasal cavity arising 
from mucosal surface of the nasal cavity or one or more than one paranasal sinuses are termed as nasal polyps. 
Nasal polyps are often found at the outflow tract of the sinuses1. Children with allergic rhinitis, allergic fungal 
sinusitis or chronic sinusitis are prone the development of nasal polyps in their nasal cavity. A polyp by nature 
could any of the following; antral-choanal polyp, malignant or benign tumor or a massive benign polyp2. 
Patient present with the complaints of nasal obstruction, watery rhinorrhea, sneezing, itchy eyes, anosmia and 
headache.3 On examination with nasal speculum or endoscope, smooth, grey, glossy lesions hanging from narrow 
stalk are seen. Nasal polyps are soft, mobile and non-tender on palpation. Diagnosis is confirmed by coronal CT 
scan with bone window.4 
Almost 4 percent of the population is affected by nasal polyps making it a highly common finding. Recurrence 
of the polyposis is very common with severe disease reported up to 10% of patients. Reoccurrence of polyps is 
quite common with medical treatment. Occurrence of nasal polyps in male to female ratio in adult population is 
approximately 2:4:1. Occurrence of multiple polyps usually happens in patients older than 20 years and is most 
commonly found in age group of 40 or above years. Nasal polyps rarely occur in children younger than 10 years. 
Management of nasal polyposis consists of medical therapy and surgery. Medical options vary and include 
topical and oral steroids. Polypectomy and functional endoscopic sinus surgery are the available surgical 
treatments of nasal polyps.5 Polypectomy seems to represent a valuable procedure and it is first-hand surgical 
procedure for treating nasal polyps.6 
Elimination or nasal polyps and symptoms of rhinitis and to establish olfaction and nasal breathing and 
prevention of recurrence of nasal polyps are few objectives considered when starting medical management of nasal 
polyposis i.e. glucocorticosteroids. Medical management of nasal polyposis has evident effect on signs and 
symptoms of nasal polyps. In mild cases of nasal polyps steroids can be used as long term therapy as alone or in 
combination for severe cases of nasal polyp alongwith systemic steroids or surgery. Use of systemic steroids also 
known as medical polypectomy has beneficial effect on all signs and symptoms’ including sense of smell etc. but 
it is still not considered as a definite mode of treatment of nasal polyps. Owing to the risk of adverse effects related 
to long term use of steroids these are usually recommended in short term cases only7. 
Long-term use, presents a risk of hypothalamic-pituitary-adrenal axis suppression, cataract formation, growth 
retardation, nasal bleeding, and, nasal septal perforation.8and long term use is contraindicated in patients with 
asthma, diabetes and in hypertension. 9 
The patient may require surgical intervention if severe symptoms of obstruction and infection prove refractory 
to medical treatment. Surgical treatment includes simple removal with snare/Tilley Henckle’s forceps or removal 
of polyps using FESS technique 10, 11. Previous literature has shown that in patients with higher load of sinunasal 
polyps, surgical polypectomy can result in extensive reduction in polyps and thus can lead in betterment in quality 
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of life and nasal obstruction. 
The rationale of comparing steroid use in comparison with intranasal polypectomy for the treatment of nasal 
polyps is that Nishtar hospital is a tertiary care hospital giving health facilities to many people living in that area, 
so this study would be helpful for patients suffering from nasal polyps by giving them a definitive, cost effective 
and better treatment of their problem. 
 
Material and Method 
This study is a randomized control trail. It was conducted in Otorhinolaryngeology Department of Nishtar Hospital 
Multan from 1st December 2017 to 1st June 2018. Ethical approval for this study was obtained from Hospital Ethics 
Committee. A total of 50 patients were added to the study after getting informed consent. Sample size was 
calculated using the reference study conducted by AA Malik14. Non probability consecutive type of sampling 
technique was used to collect the sample. Inclusion criteria was as follows; Signs and symptoms of nasal polyps 
or chronic rhinosinusitis requiring polypectomy, abnormalities on CT scan confirming the diagnosis of chronic 
rhinosinusitis or nasal polyps, patients aged 18 or older. Patients already using systemic corticosteroids or other 
medication influencing nasal mucosa during the study, patients with previous nasal surgery in past 6 weeks, history 
of ASA intolerance, pregnancy, cystic fibrosis, serious concurrent disease were excluded from the study. All fifty 
patients were divided into two equal groups, M and S with 25 patients in each. Polyps were graded from 0 to 3 on 
the basis of its growth and morphology where 0=no polyps, 1=mild polyposis, 2=moderate polyposis and 3=severe 
polyposis.  
All patients in Group M were given oral prednisone (30-60 mg) for 15-20 days in tapering regimen while in 
group S patients, intranasal polypectomy was done. Polypectomy was performed by same surgeon in all patients. 
The patients were followed at 4th (1st visit), 8th (2nd visit) and 12th (3rd visit) week after initiation of treatment and 
examined clinically in OPD to see the recurrence of nasal polyp. The information was collected through pre-
designed Performa. Computer software SPSS version 23 was used to analyze the data. Mean and standard deviation 
was calculated for quantitative variables such as age. Frequencies and percentages were calculated for qualitative 
variables such as gender and outcome variable i.e. recurrence. Chi-square test was applied to compare recurrence 
in both groups and P ≤ 0.05 was considered as significant. 
 
Results: 
Mean age of all the patients was 32.56±7.23 years. Both groups consisted of 25 patients each with male to female 
ratio of 1.5:1. On pretreatment visit, grade 1, 2and 3 polyps were seen in 8, 12 and 5 patients of the medical group 
while in 7, 9 and 9 patients of surgical group, respectively (p=0.441). (Table-I) Before starting the treatment, nasal 
obstruction was present in 14 and 15 patients (p=0.774), snoring was present in 18 and 16 patients (p=0.544), 
postnasal drip was present in 9 and 13 patients (p=0.254), altered sense of smell was present in 12 and 17 patients 
(p=0.152) in medical and surgical groups, respectively. Table-II 
At 1st post treatment visit, grade 0, 1 and 2 polyps were observed in 7, 12 and 6 patients of medical group, 
while in 16, 7 and 2 patients of the surgical group (p=0.033). No grade 3 polyps were seen in any group. (Table-
III) At 2nd post treatment visit, grade 0 and 1 polyps were seen in 12 and 13 patients of the medical group while in 
20 and 5 patients of the surgical group (p=0.018) with no patients having grade 2 or grade 3 polyps. At 3rd post 
treatment visit, grade 0 and 1 polyps were seen in 14 and 11 patients of the medical group while in 21 and 4 patients 
of the surgical group (p=0.031) with no patients having grade 2 or grade 3 polyps. Table-IV 
At 3rd post treatment visit, nasal obstruction was present in 7and 4 patients (p=0.306), snoring was present in 
9 and 6 patients (p=0.355), postnasal drip was present in 8 and 11 patients (p=0.382), altered sense of smell was 
present in 9 and 7 patients (p=0.544) in medical and surgical groups, respectively. Table-V 
Table-I 
Polyp grade at pre-treatment visit 
Polyp Grade Medical group Surgical group p-value 
1 8 (32%) 7 (28%)  
0.441 2 12 (48%) 9 (36%) 
3 5 (20%) 9 (36%) 
Total  25 (100%) 25 (100%) 
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Table-II 
Symptoms at pretreatment visit 
Symptom Medical group (n=25) Surgical group (n=25) p-value 
Nasal obstruction 14 (56%) 15 (60%) 0.774 
Snoring  18 (72%) 16 (64%) 0.544 
Postnasal drip 9 (36%) 13 (52%) 0.254 
Sense of smell 12 (48%) 17 (68%) 0.152 
 
Table-III 
Polyp grade at 1st post-treatment visit 
Polyp Grade Medical group (n=25) Surgical group (n=25) p-value 
0 7 (28%) 16 (64%)  
0.033 1 12 (48%) 7 (28%) 
2 6 (24%) 2 (8%) 
 
Table-IV 
Polyp grade at 2nd and 3rd post-treatment visit 
Visit Polyp Grade Medical group (n=25) Surgical group (n=25) p-value 
2nd 0 12 (48%) 20 (80%) 0.018 
1 13 (52%) 5 (20%) 
3rd 0 14 (56%) 21 (84%) 0.031 
1 11 (44%) 4 (16%) 
 
Table-V 
Symptoms at 3rd post treatment visit 
Symptom Medical group (n=25) Surgical group (n=25) p-value 
Nasal obstruction 7 (28%) 4 (16%) 0.306 
Snoring  9 (36%) 6 (24%) 0.355 
Postnasal drip 8 (32%) 11 (44%) 0.382 
Sense of smell 9 (36%) 7 (28%) 0.544 
 
Discussion 
Semi translucent edematous masses in nasal and paranasal cavities are known as nasal polyps which most 
commonly originate from the mucosa of middle turbinate, the sinuses and middle nasal meatus, and prolapsed into 
the nasal cavity. The condition seems to result from an underlying pathology and histological analysis has shown 
evidence of the exudation and retention of albumin and tissue fluid, together with localized eosinophilic 
inflammation in the polyps. 
Nasal polyposis is recurrent in many patients and requires several years of therapy. Even though, several 
studies have demonstrated that topical corticosteroids are effective in reducing the size of polyps, nasal obstruction 
symptoms after surgical treatment and the recurrent rate of polyps after polypectomy.  Efficacy of various topical 
corticosteroids like fluticasone, Budesonide momatasone in respect to dose, duration of the treatment remains 
controversial issue.12 
Mean age of the patients in current study is 32.56±7.23 years. These findings are comparable to the mean age 
of the patients in studies conducted by Farrukh MS et al13 and Malik AA et al14. However mean age was 59 years 
in a study conducted by Punekar YS et al15. In contrast Rohail A (16) showed in their results that mean age was 
25 years. In this study both groups consisted of 25 patients each with male to female ratio of 1.5:1 this is 
comparable to the multiple previous studies where nasal polyps were 2 times more prevalent in male as compared 
to female patients 13-16. Although the male-to-female ratio is 2-4:1 in adults, the ratio in children is unreported.  
Recurrence of polyp after at 3rd visit in Group M (medical group) was seen in 11 (44%) while in Group S 
(surgery group) was 4 (16%) with p-value of 0.031. In a study done by Malik AA et al14 has also concluded that 
surgical management is better than medical treatment for management of nasal polyps. They found recurrence of 
polyp after 3 months in 44% patients of steroid group and 10% of surgical group.  
Short-term treatment courses of systemic steroid combined with long-term steroid intranasal spray led to 
satisfactory results in 85% of the patients, and the mean clinical severity index was reduced by 77.7%.17 Punekar 
YS et al15 in a cohort consisted of 1,675 patients, of which, 576 patients were post-polypectomy steroid users and 
1,099 patients were steroid non-users concluded that the patients with post polypectomy intranasal steroid use 
showed lower risk for a repeat polypectomy compared to steroid non-users.  
Mygind N et al18 in his study has shown some different results. He concluded that although, intranasal and 
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systemic steroids have shown more improvement in sense of smell as compared to surgical treatment but 
obstructed symptoms still persisted in majority of cases after complete course of medical treatment. Similarly, 
RohailA et al16 in his study concluded that recurrence rate is less after surgical treatment than medical treatment 
for management of nasal polyps. He showed initial response in 52.0% patients while 48.0% patients did not show 
any response after intranasal steroid therapy. After a follow up of 1 year, he has found recurrence rate of 82% in 
intransal steroid group and only 37% in surgical group. All these previous studies also support the results of our 
study that surgical treatment is more preferable option for these particular patients. 
Nasal polyps are highly chronic in nature, as shown by the high recurrence rate in this study and in previous 
literature as well. Thus short term use of steroids has failed to control the recurrence of nasal polyps thus suggesting 
the use of combined treatment modalities including medical as well as surgical approaches in order to control the 
disease in long run19.  On the whole, it is concluded that effectiveness (in terms of non-recurrence) of intranasal 
polypectomy is less compared to steroid use in the management of intranasal polyps.  
 
Conclusion: The intranasal polypectomy is more effective in terms of non-recurrence of nasal polyps as compared 
to steroid use in the management of nasal polyps. So, we recommend that intranasal polypectomy should be used 
as a primary therapy in the management of nasal polyps for the prevention of its recurrence. 
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